Chinua Achebe’s daughter, Earns Harvard Medical School Award at US
Maureen Achebe, daughter of the late novelist Chinua Achebe, has been honored with the Brigham and Women’s Hospital 2024 Faculty Development and Diversity Awards. Additionally, she is the Director of Brigham and Women’s Hospital Sickle Cell Programme and an Instructor in Medicine at Harvard Medical School.
c.Blessing 
Maureen Achebe, daughter of the late novelist Chinua Achebe, has been honored with the Brigham and Women’s Hospital 2024 Faculty Development and Diversity Awards.
The news was shared by her brother, Chidi Achebe, who is the chairman of the African Integrated Development Enterprise Public Benefit Corporation, in a recent LinkedIn post.
RECOMMENDED: UNIUYO Student Kingsley George Graduates with First-Class Honors in Civil Engineering
The Brigham and Women’s Hospital, affiliated with Harvard Medical School in Boston, Massachusetts, informed Maureen of her award through a letter dated July 2, 2024. Chidi expressed his joy and pride in his sister's achievements by stating, “To God be the glory always! Ekenedili Chukwunna! Very big deal at Harvard! All glory to God!”
Maureen Achebe, who serves as the President of AIDE Healthcare International and an Associate Professor at Harvard Medical School, holds multiple roles within the medical field. She is the Director of Harvard University’s Brigham and Women’s Hospital Outpatient Infusion Centre, as well as the Clinical Director of the Non-Malignant Hematology Clinic.
SEE ALSO: UDUS Graduate Abdulganiyu Abdulrahman Akanbi Emerges as Overall Best Student in Islamic Studies History
Additionally, she is the Director of Brigham and Women’s Hospital Sickle Cell Programme and an Instructor in Medicine at Harvard Medical School. With qualifications including being triple-board certified in Medical Oncology, Hematology, and Internal Medicine.
Maureen's educational background includes a medical degree from the University of Port Harcourt in Nigeria, specialized training from Yale School of Medicine in Haematology and Medical Oncology, and a Master’s in Public Health from Harvard’s T.H. Chan School of Public Health. In her role as a commissioner on the Lancet Non-Communicable Disease and Injuries Nigeria Poverty Commission, Maureen provides expertise on sickle cell disease and helps shape policies. She is actively involved in clinical trials and translational research at Brigham and Women’s Hospital and played a key role in the development of two US FDA-approved drugs for SCD.
